ABSTRACT

Also, the rates of survival free of adverse events of the surgical arm of the ARTS54 and SOS108 trials are depicted. Interestingly, the survival free of major events after multivessel SES implantation seen in the present chapter and the findings observed after surgical treatment in those trials were very similar. Obviously, no formal comparison can be done between the different studies. Nevertheless, the potential benefit of SES is readily suggested by the present results, which implies the promising role of SES for the treatment of patients with multivessel disease.